… patients with LN are lower and the outcome of LN is better than in nonwhite populations.
European patients … refractory to treatment compared to black patients with LN. Although these …

… The updated recommendations will help guide physicians caring for patients with lupus
nephritis and the results of this systematic review will serve as evidence base for further future …

… Lupus nephritis (LN) is a form of glomerulonephritis that constitutes one of the most severe
… of the autoimmune disease systemic lupus erythematosus (SLE). Most patients with SLE who …

… in lupus nephritis trials are most predictive of good long-term renal function. We used data
from the Euro-Lupus Nephritis … Patients from the Euro-Lupus Nephritis Trial with proteinuria, …

… herein, we propose that the Euro-Lupus regimen is a suitable alternative to a regimen of
long-term, high-dose IV CYC, at least for European patients. Our results are consistent with …

… lupus nephritis; (ii) the intervention consisted of therapy with rituximab; (iii) studies included
European cohorts of at least 5 patients with lupus nephritis … drug on lupus nephritis, including …

… , successfully treated lupus nephritis patients with a sequential … of the Euro-Lupus Nephritis
Trial (ELNT), a European-based … -inducing therapy for proliferative lupus nephritis. AZA was …

… all studies that enrolled patients based on a clinical diagnosis of lupus nephritis or that …
sis of lupus nephritis but included patients with at least 2 histologic classes of lupus nephritis. …

… In addition, the three organizations target different audiences: EULAR and ERA address
mostly aspects related to European patient populations and healthcare systems, whereas …

… the third and fourth decade of life and somewhat later in populations of European descent.
Approximately 15–20% of patients experience the onset of SLE prior to 18 years of age. The …